Association between patient and tumor characteristics with clinical outcomes in women with ductal carcinoma in situ.
about
Effect of Referral Patterns and Treatment Type on Oncologic Outcomes for Women with Ductal Carcinoma In Situ.Older women's experience with breast cancer treatment decisionsRacial disparities in risk of second breast tumors after ductal carcinoma in situ.Accelerated partial breast irradiation through brachytherapy for ductal carcinoma in situ: factors influencing utilization and risks of second breast tumors.Clinical outcomes of ductal carcinoma in situ of the breast treated with partial mastectomy without adjuvant radiotherapyImpact of race and ethnicity on features and outcome of ductal carcinoma in situ of the breast.Human primary ductal carcinoma in situ (DCIS) subtype-specific pathology is preserved in a mouse intraductal (MIND) xenograft modelDuctal carcinoma in situ: what the pathologist needs to know and why.Obesity and future prostate cancer risk among men after an initial benign biopsy of the prostate.Lifestyle factors and the risk of a second breast cancer after ductal carcinoma in situ.Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.Disparities in breast cancer and african ancestry: a global perspective.Ductal carcinoma in situ - update on risk assessment and management.Cancer statistics: Breast cancer in situ.Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS.Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast.Factors predictive of occult nipple-areolar complex involvement in patients with carcinoma in situ of the breast.Second events following ductal carcinoma in situ of the breast: a register-based cohort study.
P2860
Q33617264-B11DC15C-93DA-4475-9020-B6243E019ECEQ33980622-28240AF0-4597-4B24-AC3D-B0E65A6E6305Q35282266-31714699-01A8-47B3-B156-55656E6CDF0CQ35624154-591A0CB1-EFBD-40C3-AF6F-C8FC9410C1F7Q35932105-6E735380-589E-4CCC-BDE2-829DCF6B682EQ36287832-73153012-196A-4C66-8A4D-96275C5A9D70Q36394968-4D57E268-AA0C-49F9-957D-25263737E32DQ36634452-4FF3BD45-857D-440E-8410-E265A81E2E94Q36968554-1AC0A06D-69B4-4352-A344-F145A2BE490EQ37633559-E060095F-B65F-4A9F-A023-6A57EB6B0223Q37843725-68A35598-632A-4EA0-BAF3-43BB2AB5FD0BQ38339360-1E96FAE2-AAC9-4B80-BF27-6BE324A88C09Q38696796-FB51B704-C1F9-4F40-B6E5-CD2DC2885949Q40473290-31A48C72-A339-4364-9608-8B79CA3B4C29Q40665794-559C32B3-C252-4796-9C31-6A9C95296F4EQ46557148-A21F638A-20B3-4344-B298-CB5A68C49A1BQ48348098-8DEA504B-2300-4F9A-A703-E1FC79D850EAQ51468737-DED95DE9-0688-412C-98A5-54FB13D21BEC
P2860
Association between patient and tumor characteristics with clinical outcomes in women with ductal carcinoma in situ.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association between patient an ...... with ductal carcinoma in situ.
@en
Association between patient an ...... with ductal carcinoma in situ.
@nl
type
label
Association between patient an ...... with ductal carcinoma in situ.
@en
Association between patient an ...... with ductal carcinoma in situ.
@nl
prefLabel
Association between patient an ...... with ductal carcinoma in situ.
@en
Association between patient an ...... with ductal carcinoma in situ.
@nl
P2093
P2860
P356
P1476
Association between patient an ...... with ductal carcinoma in situ
@en
P2093
Beth A Virnig
Robert L Kane
Todd M Tuttle
P2860
P304
P356
10.1093/JNCIMONOGRAPHS/LGQ034
P577
2010-01-01T00:00:00Z